|
Name |
Indan
|
Molecular Formula | C9H10 | |
IUPAC Name* |
2,3-dihydro-1H-indene
|
|
SMILES |
C1CC2=CC=CC=C2C1
|
|
InChI |
InChI=1S/C9H10/c1-2-5-9-7-3-6-8(9)4-1/h1-2,4-5H,3,6-7H2
|
|
InChIKey |
PQNFLJBBNBOBRQ-UHFFFAOYSA-N
|
|
Synonyms |
INDAN; Indane; 2,3-Dihydro-1H-indene; 496-11-7; Hydrindene; 1H-Indene, 2,3-dihydro-; Benzocyclopentane; 2,3-Dihydroindene; 1,2-Hydrindene; Hydrindonaphthene; Indene, 2,3-dihydro-; NSC 5292; H9SCX043IG; CHEMBL370687; CHEBI:37911; NSC-5292; Indane (VAN); EINECS 207-814-7; UNII-H9SCX043IG; Dihydroindene; AI3-02275; 16N; Indene,3-dihydro-; MFCD00003795; Indan, 95%; INDAN [MI]; Indan, analytical standard; DSSTox_CID_30701; DSSTox_GSID_52132; WLN: L56T&J; DTXSID4052132; Indan 10 microg/mL in Methanol; NSC5292; STR04252; ZINC1680824; Tox21_303879; BDBM50167998; AKOS000121540; CS-W016586; NCGC00357139-01; 56573-11-6; CAS-496-11-7; DB-051655; FT-0627193; I0011; EN300-21168; D97393; A827773; Q420109; Q-201237; F0001-1290
|
|
CAS | 496-11-7 | |
PubChem CID | 10326 | |
ChEMBL ID | CHEMBL370687 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 118.18 | ALogp: | 3.2 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 9 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.361 | MDCK Permeability: | 0.00002110 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.797 |
30% Bioavailability (F30%): | 0.633 |
Blood-Brain-Barrier Penetration (BBB): | 0.971 | Plasma Protein Binding (PPB): | 92.67% |
Volume Distribution (VD): | 2.604 | Fu: | 6.97% |
CYP1A2-inhibitor: | 0.976 | CYP1A2-substrate: | 0.778 |
CYP2C19-inhibitor: | 0.716 | CYP2C19-substrate: | 0.126 |
CYP2C9-inhibitor: | 0.196 | CYP2C9-substrate: | 0.654 |
CYP2D6-inhibitor: | 0.232 | CYP2D6-substrate: | 0.871 |
CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.255 |
Clearance (CL): | 8.264 | Half-life (T1/2): | 0.464 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.052 |
Drug-inuced Liver Injury (DILI): | 0.04 | AMES Toxicity: | 0.104 |
Rat Oral Acute Toxicity: | 0.111 | Maximum Recommended Daily Dose: | 0.126 |
Skin Sensitization: | 0.708 | Carcinogencity: | 0.468 |
Eye Corrosion: | 0.945 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.102 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000038 | 0.439 | D0MP5H | 0.488 | ||||
ENC000518 | 0.405 | D05IHU | 0.385 | ||||
ENC000673 | 0.390 | D06OMW | 0.354 | ||||
ENC001319 | 0.386 | D0E6YQ | 0.340 | ||||
ENC000681 | 0.366 | D0R8PX | 0.333 | ||||
ENC001380 | 0.352 | D0UM7O | 0.309 | ||||
ENC000159 | 0.347 | D01UTL | 0.303 | ||||
ENC000171 | 0.327 | D04WFD | 0.303 | ||||
ENC006142 | 0.326 | D0N7AD | 0.296 | ||||
ENC005244 | 0.326 | D0Y5UG | 0.294 |